Madrigal Pharmaceuticals, Inc. ( MDGL) - Stock Earnings
MDGL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
MDGL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -58.6 million USD | 321.1 million USD |
| 2026Q1 | -94.4 million USD | 311.3 million USD |
| 2026Q2 | -57.9 million USD | 364.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MDGL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -373.6 million USD | — USD |
| 2024 | -465.9 million USD | 180.1 million USD |
| 2025 | -288.3 million USD | 958.4 million USD |
| 2026 Est. | — | — |
MDGL
Price: $471.75
52 week price:
Earnings Per Share: -14.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 132314
Ebitda: -8.4 millionMarket Capitalization: 11.5 billion